Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients
Prescrire international 17(97): 195
2008
ISSN/ISBN: 1167-7422 PMID: 19534047 Document Number: 621884
In patients treated with anthracyclines, the addition of dexrazoxane moderately reduces the risk of symptomatic heart failure. But dexrazoxane increases the haematological toxicity induced by chemotherapy and might also reduce its antitumour efficacy.
Document emailed within 1 workday
Related Documents
Orditura, M.; De Vita, F.; Ciaramella, F.; Catalano, G. 1994: Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 9(4): 243-248Ali, A.A.S.; Al-Mudhafar, A.M.J. 2011: Prediction of anthracycline induced cardiotoxicity: study of thirty-one Iraqi adult patients Gulf Journal of Oncology 10: 33-39
Wojtukiewicz, M.Z.; Omyła, J.; Kozłowski, L.; Szynaka, B. 2000: Cardiotoxicity of anthracycline Postepy Higieny i Medycyny Doswiadczalnej 54(4): 467-485
Lipshultz, S.E.; Sanders, S.P.; Goorin, A.M.; Krischer, J.P.; Sallan, S.E.; Colan, S.D. 1994: Monitoring for anthracycline cardiotoxicity Pediatrics 93(3): 433-437
Rivero, O.; Mordeglia, F. 1987: Epirubicin: an anthracycline of minor cardiotoxicity Medicina 47(3): 320-321
McGuire, W.P. 1978: Prospective monitoring for anthracycline cardiotoxicity: an introduction Cancer Treatment Reports 62(6): 855
Ferrans, V.J. 1978: Overview of cardiac pathology in relation to anthracycline cardiotoxicity Cancer Treatment Reports 62(6): 955-961
De Leonardis, V.; De Scalzi, M.; Neri, B.; Bartalucci, S.; Cinelli, P. 1987: Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens International Journal of Clinical Pharmacology Research 7(4): 307-311
Okada, Y.; Horikawa, K.; Sano, M. 1997: Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(5): 585-589
McGovren, J.P.; Neil, G.L.; Denlinger, R.H.; Hall, T.L.; Crampton, S.L.; Swenberg, J.A. 1979: Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent Cancer Research 39(12): 4849-4855
Lemez, P.; Maresová, J. 1996: Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias Neoplasma 43(6): 417-419
Liu, L.; Liu, Z-zhe.; Liu, Y-ye.; Zheng, Z-dong.; Liang, X-feng.; Han, Y-ling.; Xie, X-dong. 2013: Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 35(12): 936-940
Patel, C.D.; Balakrishnan, V.B.; Kumar, L.; Naswa, N.; Malhotra, A. 2010: Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity? Hellenic Journal of Nuclear Medicine 13(3): 233-237
Chanan-Khan, A.; Srinivasan, S.; Czuczman, M.S. 2004: Prevention and management of cardiotoxicity from antineoplastic therapy Journal of Supportive Oncology 2(3): 251-6; Discussion 259-61 264-6
Protasov, D.A.; Zel'dovich, D.R.; Kuz'mina, L.P.; Manikhas, G.M. 1998: The role of cardioxane (ICRF-187) in the prevention of cardiotoxicity of anthracyclines in the combined drug therapy of extensive ovarian cancer Voprosy Onkologii 44(6): 718-721
Swain, S.M. 1998: Adult multicenter trials using dexrazoxane to protect against cardiac toxicity Seminars in Oncology 25(4 Suppl 10: 43-47
Mladosievicova, B.; Foltinová, A.; Petrásová, H.; Bernadic, M.; Hulín, I. 2001: Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane Neoplasma 48(1): 61-65
Sidorova, T.A.; Gerasimova, G.K.; Lepkov, S.V.; Volkova, M.A. 1992: Biochemical indicators of anthracycline sensitivity of blast cells from patients with hemoblastoses Antibiotiki i Khimioterapiia 37(5): 17-20
Scherrer-Crosbie, M. 2013: Markers of cardiotoxicity in breast cancer patients Clinical Advances in Hematology and Oncology: H&o 11(1): 41-42
Haruyama, H.; Shimazaki, C.; Nakanishi, S.; Hamami, T.; Nisio, A.; Isemura, T.; Katsume, H.; Nakagawa, M.; Ijichi, H. 1982: Cardiotoxicity of daunorubicin and aclacinomycin a in patients with acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 516-521